AILAH VAZQUEZ: Open Payments
NPI 1073255352 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,467 in 69 payments from 17 companies in 2025. Trend: 2023 $516 · 2024 $1,652 · 2025 $1,467
Food & beverage: $1,422Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $408 |
| AstraZeneca Pharmaceuticals LP | 11 | $203 |
| Lilly USA, LLC | 6 | $144 |
| GlaxoSmithKline, LLC. | 5 | $121 |
| ABBVIE INC. | 6 | $113 |
| Astellas Pharma US Inc | 4 | $103 |
| Antares Pharma, Inc. | 4 | $71 |
| PFIZER INC. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Dexcom, Inc. | 1 | $40 |
Products named: Wegovy, Ozempic, VRAYLAR, AIRSUPRA, Veozah, MOUNJARO, FARXIGA, XYOSTED.
Industry payments across GA — which companies pay providers there.
